Back
Speaker illustration

Doctor Aristi Boulmpou

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)

Member of:

European Society of Cardiology
European Association of Cardiovascular Imaging

Aristi Boulmpou is a Cardiologist based on Thessaloniki, Greece. She obtained her M.D. degree in 2011 from the Aristotle University of Thessaloniki and completed a Master of Science in Healthcare Management at the University of Macedonia in 2019. She received her clinical training in Internal Medicine and Cardiology and developed a special interest in cardiovascular imaging. She completed her PhD at the Aristotle University of Thessaloniki in 2025, focusing on the prognosis of paroxysmal atrial fibrillation recurrences. She is currently being trained in advanced echocardiography in the Third Department of Cardiology of the Aristotle University of Thessaloniki.

Presentations

Right and left heart functional indices and coupling parameters in the prediction of arrhythmia recurrence among patients with paroxysmal atrial fibrillation

Event: EACVI 2025

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Atrio-ventricular coupling: the new kid on the block to be assessed

Access
Like
Thumbnail

How to write a research paper – what the Editor is looking for? (Endorsed by Hellenic Young Cardiologists WG)-Young Panelist (Local Faculty)

Event: ESC Heart & Stroke 2024

Topic: Stroke

Session: Clinical cases and Guidelines

Access
Like
Thumbnail

Serum magnesium and phosphorus values are lower among patients with paroxysmal atrial fibrillation: insights from the PLACEBO study

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Pathophysiology and mechanisms of atrial fibrillation

Access
Like
Thumbnail

Syncopal patients without prodromes exhibit a diverse pattern of adenosine release during head-up tilt test

Event: ESC Congress 2022

Topic: Noninvasive Diagnostic Methods

Session: Non-invasive diagnostic methods for various arrhythmias

Access
Like
Thumbnail

Prevalence of atrial myopathy among hypertrophic cardiomyopathy patients without atrial fibrillation

Event: ESC Congress 2022

Topic: Myocardial Disease

Session: The importance of left atrial assessment with echocardiography

Access
Like
Thumbnail

Impact of antidiabetic treatment with dipeptidyl peptidase-4 inhibitors on the risk of cardiac arrhythmias among patients with type 2 diabetes mellitus

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Access
Like
Thumbnail

Sodium-glucose co-transporter-2 inhibitors and the risk of major arrhythmias: a meta-analysis of the cardiovascular and renal outcome trials

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Access
Like
Thumbnail

Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Access
Like
Thumbnail

Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Access
Like
Thumbnail

The effect of glucagon-like peptide-1 receptor agonists on 24-hour ambulatory blood pressure: a meta-analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources